According to other authors, the activation of PPAR-γ relieves symptoms associated with cognitive dysfunctions and obesity, and improves the level of brain-derived neurotrophic factor (BDNF), which is reduced in depression and type 2 diabetes [9,70]. Here, PPARG is linked to depressive symptom measurement.